Pfizer Announces Positive Top-line Results Of A Phase 2 Study Of TRUMENBAÂ® (Meningococcal Group B Vaccine) Co-Administered With Routine Meningococcal (A, C, Y, and W) And Tetanus, Diptheria And Pertussis (Tdap) Vaccines In 